scholarly journals Antipsychotic treatment effects and structural MRI brain changes in schizophrenia

2021 ◽  
pp. 1-10
Author(s):  
Robin Emsley ◽  
Stefan du Plessis ◽  
Lebogang Phahladira ◽  
Hilmar K. Luckhoff ◽  
Frederika Scheffler ◽  
...  

Abstract Background Progressive brain structural MRI changes are described in schizophrenia and have been ascribed to both illness progression and antipsychotic treatment. We investigated treatment effects, in terms of total cumulative antipsychotic dose, efficacy and tolerability, on brain structural changes over the first 24 months of treatment in schizophrenia. Methods A prospective, 24-month, single-site cohort study in 99 minimally treated patients with first-episode schizophrenia, schizophreniform and schizoaffective disorder, and 98 matched healthy controls. We treated the patients according to a fixed protocol with flupenthixol decanoate, a long-acting injectable antipsychotic. We assessed psychopathology, cognition, extrapyramidal symptoms and BMI, and acquired MRI scans at months 0, 12 and 24. We selected global cortical thickness, white matter volume and basal ganglia volume as the regions of interest. Results The only significant group × time interaction was for basal ganglia volumes. However, patients, but not controls, displayed cortical thickness reductions and increases in white matter and basal ganglia volumes. Cortical thickness reductions were unrelated to treatment. White matter volume increases were associated with lower cumulative antipsychotic dose, greater improvements in psychopathology and cognition, and more extrapyramidal symptoms. Basal ganglia volume increases were associated with greater improvements in psychopathology, greater increases in BMI and more extrapyramidal symptoms. Conclusions We provide evidence for plasticity in white matter and basal ganglia associated with antipsychotic treatment in schizophrenia, most likely linked to the dopamine blocking actions of these agents. Cortical changes may be more closely related to the neurodevelopmental, non-dopaminergic aspects of the illness.

2014 ◽  
Vol 20 (2) ◽  
pp. 168-180 ◽  
Author(s):  
Lily Riggs ◽  
Eric Bouffet ◽  
Suzanne Laughlin ◽  
Normand Laperriere ◽  
Fang Liu ◽  
...  

AbstractChildren treated for medulloblastoma (MB) exhibit long-term impairments in declarative memory, but the pathophysiology underlying this is unclear. Previous studies report declines in global white matter volume, but have failed to link this to declines in memory performance. We examined the effects of treatment on measures ofglobalbrain structure (i.e., total white and gray matter volume) andspecificmemory structures (i.e., hippocampus and uncinate fasciculus). We used volumetric MRI and diffusion tensor imaging in pediatric survivors of MB and one survivor of astrocytoma treated with cranial-spinal radiation (n= 20), and healthy controls (n= 13). Compared to controls, the survivor group exhibited reduced white matter volume, damage to the uncinate fasciculus, and a smaller right hippocampus. Critically, reduced hippocampal volume was not related to differences in brain volume, suggesting that the hippocampus may be especially vulnerable to treatment effects. A subset of the survivors (n= 10) also underwent memory testing using the Children's Memory Scale (CMS). Performance on the general index of the CMS was significantly correlated with measures of hippocampal volume and uncinate fasciculus. The examination of treatment effects on specific brain regions provides a better understanding of long-term cognitive outcome in children with brain tumors, particularly medulloblastoma. (JINS, 2014,1, 1–13)


2021 ◽  
Author(s):  
Michal Rafal Zareba ◽  
Magdalena Fafrowicz ◽  
Tadeusz Marek ◽  
Ewa Beldzik ◽  
Halszka Oginska ◽  
...  

Abstract Humans can be classified as early, intermediate and late chronotypes based on the preferred sleep and wakefulness patterns. The anatomical basis of these distinctions remains largely unexplored. Using magnetic resonance imaging data from 113 healthy young adults (71 females), we aimed to replicate cortical thickness and grey matter volume chronotype differences reported earlier in the literature using a greater sample size, as well as to explore the volumetric white matter variation linked to contrasting circadian phenotypes. Instead of comparing the chronotypes, we correlated the individual chronotype scores with their morphometric brain measures. The results revealed one cluster in the left fusiform and entorhinal gyri showing increased cortical thickness with increasing preference for eveningness, potentially providing an anatomical substrate for chronotype-sensitive affective processing. No significant results were found for grey and white matter volume. We failed to replicate cortical thickness and volumetric grey matter distinctions in the brain regions reported in the literature. Furthermore, we found no association between white matter volume and chronotype. Thus, while this study confirms that circadian preference is associated with specific structural substrates, it adds to the growing concerns that reliable and replicable neuroimaging research requires datasets much larger than those commonly used.


2009 ◽  
Vol 20 (3) ◽  
pp. 534-548 ◽  
Author(s):  
Christian K. Tamnes ◽  
Ylva Østby ◽  
Anders M. Fjell ◽  
Lars T. Westlye ◽  
Paulina Due-Tønnessen ◽  
...  

2021 ◽  
Author(s):  
Michal Rafal Zareba ◽  
Magdalena Fafrowicz ◽  
Tadeusz Marek ◽  
Ewa Beldzik ◽  
Halszka Oginska ◽  
...  

Abstract Humans can be classified as early, intermediate and late chronotypes based on the preferred sleep and wakefulness patterns. The anatomical basis of these distinctions remains largely unexplored. Using magnetic resonance imaging data from 113 healthy young adults (71 females), we aimed to replicate cortical thickness and grey matter volume chronotype differences reported earlier in the literature using a greater sample size, as well as to explore the volumetric white matter variation linked to contrasting circadian phenotypes. Instead of comparing the chronotypes, we correlated the individual chronotype scores with their morphometric brain measures. The results revealed one cluster in the left fusiform and entorhinal gyri showing increased cortical thickness with increasing preference for eveningness, potentially providing an anatomical substrate for chronotype-sensitive affective processing. No significant results were found for grey and white matter volume. We failed to replicate cortical thickness and volumetric grey matter distinctions in the brain regions reported in the literature. Furthermore, we found no association between white matter volume and chronotype. Thus, while this study confirms that circadian preference is associated with specific structural substrates, it adds to the growing concerns that reliable and replicable neuroimaging research requires datasets much larger than those commonly used.


NeuroImage ◽  
2014 ◽  
Vol 101 ◽  
pp. 59-67 ◽  
Author(s):  
Michelle M. Autrey ◽  
Lisa A. Reamer ◽  
Mary Catherine Mareno ◽  
Chet C. Sherwood ◽  
James G. Herndon ◽  
...  

2021 ◽  
Vol 22 (9) ◽  
pp. 4953
Author(s):  
Natalie M. Zahr ◽  
Kilian M. Pohl ◽  
Allison J. Kwong ◽  
Edith V. Sullivan ◽  
Adolf Pfefferbaum

Classical inflammation in response to bacterial, parasitic, or viral infections such as HIV includes local recruitment of neutrophils and macrophages and the production of proinflammatory cytokines and chemokines. Proposed biomarkers of organ integrity in Alcohol Use Disorders (AUD) include elevations in peripheral plasma levels of proinflammatory proteins. In testing this proposal, previous work included a group of human immunodeficiency virus (HIV)-infected individuals as positive controls and identified elevations in the soluble proteins TNFα and IP10; these cytokines were only elevated in AUD individuals seropositive for hepatitis C infection (HCV). The current observational, cross-sectional study evaluated whether higher levels of these proinflammatory cytokines would be associated with compromised brain integrity. Soluble protein levels were quantified in 86 healthy controls, 132 individuals with AUD, 54 individuals seropositive for HIV, and 49 individuals with AUD and HIV. Among the patient groups, HCV was present in 24 of the individuals with AUD, 13 individuals with HIV, and 20 of the individuals in the comorbid AUD and HIV group. Soluble protein levels were correlated to regional brain volumes as quantified with structural magnetic resonance imaging (MRI). In addition to higher levels of TNFα and IP10 in the 2 HIV groups and the HCV-seropositive AUD group, this study identified lower levels of IL1β in the 3 patient groups relative to the control group. Only TNFα, however, showed a relationship with brain integrity: in HCV or HIV infection, higher peripheral levels of TNFα correlated with smaller subcortical white matter volume. These preliminary results highlight the privileged status of TNFα on brain integrity in the context of infection.


Sign in / Sign up

Export Citation Format

Share Document